Results of Implementation of Amyloidosis Screening for Patients Undergoing Carpal Tunnel Release
The Journal of Hand Surgery · 2024
DOI: 10.1016/j.jhsa.2022.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Hand Surgery, 2024. Verfasst von Nicholas P Gannon und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN. Hauptthemen laut MEDLINE: Carpal Tunnel Syndrome, Amyloidosis. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Many patients with amyloidosis undergo carpal tunnel release (CTR) before amyloidosis diagnosis and before developing cardiac or other serious disease manifestations. The purposes of this study were to examine if our patient population had a similar prevalence of positive amyloidosis diagnoses to that in prior studies and to describe the results of implementing a screening program for amyloidosis. METHODS: We retrospectively reviewed the biopsy results and subsequent interventions for all patients who underwent screening tenosynovial biopsy during CTR from March 2020 through December 2021. Amyloid screening was offered to patients who met the criteria for increased risk of disease using an appropriateness screening algorithm. RESULTS: Seventy-five (48%) of 156 patients who underwent CTR met the eligibility criteria for amyloidosis testing. Of the 62 patients who agreed to undergo tenosynovial biopsy, 14 had amyloid-positive biopsy specimens (10 men and 4 women). All patients with positive tenosynovial biopsies had bilateral carpal tunnel syndrome and wild-type transthyretin amyloid subtype. One patient was diagnosed and started treatment for otherwise asymptomatic cardiac amyloidosis. CONCLUSIONS: The incidence of amyloid-positive tenosynovial biopsy results from CTR was 22.5% in patients using the criteria from an appropriateness screening algorithm, which was higher than previously reported. Implementation of a screening program for patients undergoing CTR requires a multidisciplinary approach and may result in early diagnosis and lifesaving interventions for patients with amyloidosis. TYPE OF STUDY/LEVEL OF EVIDENCE: Differential diagnosis/symptom prevalence study, II.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN.
- Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN; Department of Orthopaedic Surgery, Regions Hospital, Saint Paul, MN. Electronic address: Christina.M.Ward@healthpartners.com.
Zitieren
APA
Gannon, N. P., & Ward, C. M. (2024). Results of Implementation of Amyloidosis Screening for Patients Undergoing Carpal Tunnel Release. The Journal of Hand Surgery. https://doi.org/10.1016/j.jhsa.2022.09.005
Vancouver
Gannon NP, Ward CM. Results of Implementation of Amyloidosis Screening for Patients Undergoing Carpal Tunnel Release. The Journal of Hand Surgery. 2024. doi:10.1016/j.jhsa.2022.09.005
BibTeX
@article{Gannon2024,
author = {Gannon, Nicholas P and Ward, Christina M},
title = {Results of Implementation of Amyloidosis Screening for Patients Undergoing Carpal Tunnel Release},
journal = {The Journal of Hand Surgery},
year = {2024},
doi = {10.1016/j.jhsa.2022.09.005}
}
EUVIMED